Showing 20 of 173 recruiting trials for “squamous-cell-carcinoma-of-the-oropharynx”
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
RecruitingNCT07088354 ↗
Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
RecruitingNCT06831357 ↗
Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy
👨⚕️ Jinming Yu, Dr., Shandong Cancer Hospital and Institute📍 1 site📅 Started Jan 2025View details ↗
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.
CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma
Enrolling by InvitationNCT06763640 ↗
Prognostic Value of TIL in Nasopharyngeal Carcinoma
A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
👨⚕️ Yunpeng Zhao, doctor, The Second Qilu Hospital of Shandong University📍 1 site📅 Started Dec 2024View details ↗
Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
👨⚕️ Zhihao Lu, MD, Peking University Cancer Hospital & Institute📍 1 site📅 Started Nov 2024View details ↗
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →